Your browser doesn't support javascript.
loading
The Effects of n-3 PUFA Supplementation on Bone Metabolism Markers and Body Bone Mineral Density in Adults: A Systematic Review and Meta-Analysis of RCTs.
Gao, Jie; Xie, Chenqi; Yang, Jie; Tian, Chunyan; Zhang, Mai; Lu, Zhenquan; Meng, Xiangyuan; Cai, Jing; Guo, Xiaofei; Gao, Tianlin.
Afiliación
  • Gao J; School of Public Health, Qingdao University, Qingdao 266071, China.
  • Xie C; Institute of Nutrition & Health, Qingdao University, Qingdao 266021, China.
  • Yang J; School of Public Health, Qingdao University, Qingdao 266071, China.
  • Tian C; Institute of Nutrition & Health, Qingdao University, Qingdao 266021, China.
  • Zhang M; Health Service Center of Xuejiadao Community, Qingdao 266520, China.
  • Lu Z; School of Public Health, Qingdao University, Qingdao 266071, China.
  • Meng X; Institute of Nutrition & Health, Qingdao University, Qingdao 266021, China.
  • Cai J; School of Public Health, Qingdao University, Qingdao 266071, China.
  • Guo X; School of Public Health, Qingdao University, Qingdao 266071, China.
  • Gao T; School of Public Health, Qingdao University, Qingdao 266071, China.
Nutrients ; 15(12)2023 Jun 19.
Article en En | MEDLINE | ID: mdl-37375709
ABSTRACT
Supplemental n-3 polyunsaturated fatty acids (PUFA) on bone metabolism have yielded inconsistent results. This study aimed to examine the effects of n-3 PUFA supplementation on bone metabolism markers and bone mineral density through a meta-analysis of randomized controlled trials. A systematic literature search was conducted using the PubMed, Web of Science, and EBSCO databases, updated to 1 March 2023. The intervention effects were measured as standard mean differences (SMD) and mean differences (MD). Additionally, n-3 PUFA with the untreated control, placebo control, or lower-dose n-3 PUFA supplements were compared, respectively. Further, 19 randomized controlled trials (RCTs) (22 comparisons, n = 2546) showed that n-3 PUFA supplementation significantly increased blood n-3 PUFA (SMD 2.612; 95% CI 1.649 to 3.575). However, no significant effects were found on BMD, CTx-1, NTx-1, BAP, serum calcium, 25(OH)D, PTH, CRP, and IL-6. Subgroup analyses showed significant increases in femoral neck BMD in females (0.01, 95% CI 0.01 to 0.02), people aged <60 years (0.01, 95% CI 0.01 to 0.01), and those people in Eastern countries (0.02, 95% CI 0.02 to 0.03), and for 25(OH)D in people aged ≥60 years (0.43, 95% CI 0.11 to 0.74), treated with n-3 PUFA only (0.36, 95% CI 0.06 to 0.66), and in studies lasting ≤6 months (0.29, 95% CI 0.11 to 0.47). NTx-1 decreased in both genders (-9.66, 95% CI -15.60 to -3.71), and serum calcium reduction was found in studies lasting >6 months (-0.19, 95% CI -0.37 to -0.01). The present study demonstrated that n-3 PUFA supplementation might not have a significant effect on bone mineral density or bone metabolism markers, but have some potential benefits for younger postmenopausal subjects in the short term. Therefore, additional high-quality, long-term randomized controlled trials (RCTs) are warranted to fully elucidate the potential benefits of n-3 PUFA supplementation, as well as the combined supplementation of n-3 PUFA, on bone health.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ácidos Grasos Omega-3 Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Adult / Female / Humans Idioma: En Revista: Nutrients Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ácidos Grasos Omega-3 Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Adult / Female / Humans Idioma: En Revista: Nutrients Año: 2023 Tipo del documento: Article País de afiliación: China